Evaluates the advantages and disadvantages of hormone replacement therapy considering: breast cancer, bone metabolism (osteoporosis), thrombosis and long-term exposure to estrogenes. Please consider our important information in the attachement below!

Evaluates pregnancy complications such as gestosis, thrombosis, recurrent abortion. We recommend this sensor especially during the first pregnancy.

Evaluates the risk of prostate cancer as well as the risk for thrombosis, osteoporosis, metabolic imbalances of detoxification and chronic inflammation.

Evaluation of the genetic associated risk of prostate cancer.

Evaluation of genetically associated risks of obesity, insulin resistance and type 2 diabetes, hypertension, inflammation and imbalance of lipoprotein- and glucose-metabolism.

To optimize a therapy in case of cardiovascular disease and / or in case of existing cardiovascular risk factors like
hypertension, arrhythmia, arteriosclerosis, disorders in glucose– and lipid metabolism, type 2 diabetes, obesity,
coronary artery disease, hyperhomocysteinemia, status post thrombosis and status post myocardial infarction or
adverse reactions to cardiovascular pharmaceuticals, as well as in case of risk burdens within the family and in
order to identify individuals, who especially would benefit either from medication, dietary intervention or lifestyle
modification to lower their cardiovascular risk.

Identification of genetic variations which influence the processing of nutriments in the human body. The test  results allow to compose a special nutrition scheme for your individual needs.

Identification of genetic variations which influence metabolism, efficiency and adverse effects of medication.

This comprehensive test includes a cardiological part, a pharmacogenetical part and a gynecological/andrological part.